The evaluation of ROM and OXY has been largely evaluated in terms of analytical values and clinical significance (levels in general populations and cardiovascular disease patients, as well as predictors of adverse CV events in CAD) and in a different clinical setting by us and other authors [6,7,8,26,27]. The gene discussed is GCG; the disease is coronary artery disorder.